Literature DB >> 33414631

Small intestinal thrombotic microangiopathy following kidney transplantation diagnosed by balloon-assisted enteroscopy.

Masafumi Nishio1, Kingo Hirasawa1, Jun-Ichi Teranishi2, Koki Maeda3, Yuichiro Ozeki1, Atsushi Sawada1, Ryosuke Ikeda1, Takehide Fukuchi1, Ryosuke Kobayashi1, Makomo Makazu1, Chiko Sato1, Yoshiaki Inayama3, Shin Maeda4.   

Abstract

Thrombotic microangiopathy (TMA) is a serious complication following kidney transplantation. Although intestinal TMA is a major organ injury and causes abdominal pain, diarrhea and bloody stools, the clinical and endoscopic characteristics of small intestinal TMA remain unclear. Here, we report a drug-induced small intestinal TMA, which did not meet the laboratory-defined TMA criteria but was diagnosed by balloon-assisted enteroscopy (BAE). A 32-year-old woman who underwent kidney transplantation at the age of 10 years complained of abdominal pain, diarrhea and bloody stools one month after starting everolimus (EVE) as an immunosuppressant. Although she did not meet the diagnostic criteria for TMA serologically, BAE revealed a circumferential ulcer in the jejunum, and the pathological findings of a biopsy specimen showed microvascular thrombi, compatible with intestinal TMA. Her symptoms improved upon the discontinuation of EVE, demonstrating that EVE can cause drug-induced intestinal TMA. The present case suggests that BAE should be performed when abdominal pain, diarrhea, and bloody stools occur in patients receiving immunosuppressive medication following kidney transplantation, even if there is no evidence of TMA according to the laboratory definition. Copyright:
© 2021 Hellenic Society of Gastroenterology.

Entities:  

Keywords:  Thrombotic microangiopathy; balloon-assisted enteroscopy; everolimus; kidney transplantation; small intestine

Year:  2020        PMID: 33414631      PMCID: PMC7774655          DOI: 10.20524/aog.2020.0561

Source DB:  PubMed          Journal:  Ann Gastroenterol        ISSN: 1108-7471


  10 in total

1.  Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group.

Authors:  Tapani Ruutu; Giovanni Barosi; Richard J Benjamin; Richard E Clark; James N George; Alois Gratwohl; Ernst Holler; Massimo Iacobelli; Karim Kentouche; Bernhard Lämmle; Joel L Moake; Paul Richardson; Gerard Socié; Zella Zeigler; Dietger Niederwieser; Tiziano Barbui
Journal:  Haematologica       Date:  2007-01       Impact factor: 9.941

2.  Clinical challenges and images in GI. Image 4. Transplant-associated thrombotic microangiopathy of the colon accompanied by graft-versus-host disease.

Authors:  Shuji Yamamoto; Hiroshi Nakase; Tsutomu Chiba; Kouhei Yamashita; Masafumi Ito
Journal:  Gastroenterology       Date:  2009-05-03       Impact factor: 22.682

3.  Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy.

Authors:  Y Inamoto; M Ito; R Suzuki; T Nishida; H Iida; A Kohno; M Sawa; M Murata; S Nishiwaki; T Oba; M Yanada; T Naoe; R Ichihashi; M Fujino; T Yamaguchi; Y Morishita; N Hirabayashi; Y Kodera; K Miyamura
Journal:  Bone Marrow Transplant       Date:  2009-01-12       Impact factor: 5.483

4.  Impact of treatment and outcomes for patients with posttransplant drug-associated thrombotic microangiopathy.

Authors:  Narendranath Epperla; Kathleen Hemauer; Mehdi Hamadani; Kenneth D Friedman; Lisa Baumann Kreuziger
Journal:  Transfusion       Date:  2017-08-23       Impact factor: 3.157

5.  Intestinal thrombotic microangiopathy following reduced-intensity umbilical cord blood transplantation.

Authors:  H Narimatsu; M Kami; S Hara; T Matsumura; S Miyakoshi; E Kusumi; Y Kakugawa; Y Kishi; N Murashige; K Yuji; K Masuoka; A Yoneyama; A Wake; S Morinaga; Y Kanda; S Taniguchi
Journal:  Bone Marrow Transplant       Date:  2005-09       Impact factor: 5.483

6.  Thrombotic micro-angiopathy with sirolimus-based immunosuppression: potentiation of calcineurin-inhibitor-induced endothelial damage?

Authors:  Michael Robson; Isabelle Côte; Ian Abbs; Geoffrey Koffman; David Goldsmith
Journal:  Am J Transplant       Date:  2003-03       Impact factor: 8.086

7.  Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease.

Authors:  T Nishida; M Hamaguchi; N Hirabayashi; M Haneda; S Terakura; Y Atsuta; S Imagama; T Kanie; M Murata; H Taji; R Suzuki; Y Morishita; Y Kodera
Journal:  Bone Marrow Transplant       Date:  2004-06       Impact factor: 5.483

8.  Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin-sirolimus combination.

Authors:  Marie-Chantal Fortin; Marc-André Raymond; François Madore; Jo-Ann Fugère; Michel Pâquet; Gilles St-Louis; Marie-Josée Hébert
Journal:  Am J Transplant       Date:  2004-06       Impact factor: 8.086

Review 9.  De novo thrombotic microangiopathy after kidney transplantation.

Authors:  Neetika Garg; Helmut G Rennke; Martha Pavlakis; Kambiz Zandi-Nejad
Journal:  Transplant Rev (Orlando)       Date:  2017-11-04       Impact factor: 3.943

10.  Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.

Authors:  Christoph Nunius; Maike Büttner-Herold; Simone Bertz; Mario Schiffer; Bjoern Buchholz
Journal:  BMC Nephrol       Date:  2020-03-24       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.